Drug Pricing

Securing Affordable Treatments for All Americans

Anticompetitive practices within the pharmaceutical industry, coupled with outdated patent laws that inhibit more affordable biosimilars and generics, have resulted in skyrocketing drug costs for all Americans – but especially seniors and those with chronic conditions. ACHP advocates for sensible policies such as price transparency to rein in sky-high costs so that patients can afford the medications they need.

Facts & Figures

icon

ACHP plans partner with

Civica Rx

to address drug shortages and high prices.

image-card

FACT SHEET — Curbing High Drug Costs

Download
Resource Library Search

Overcoming Barriers: Transforming Black Maternal Health Through Research Webinar

ACHP's Dr. Jennifer Lee joined UCare's Dr. Tenbit Emiru, UT Health Houston School of Public Health's Dr. Derwaa Omowale and Priority Health's Dr. Shannon Wilson to highlight key areas of …

04/18/2024

PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast

ACHP’s Ceci Connolly and the Association of Community Affiliated Plans’ Meg Murray kicked off the inaugural episode of Managed Healthcare Executive’s DC Roundtable Podcast.

04/10/2024

OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?

ACHP President and CEO Ceci Connolly coauthored an op-ed examining if the obesity epidemic could be solved with free GLP-1s.

04/10/2024

ACHP Statement on Final Rule for Medicare Advantage and Part D

ACHP applauds CMS for curtailing excessive payments to MA brokers and in a final rule that includes ACHP policy proposals.

04/04/2024

WEBINAR: Medicare Advantage in 2024 and Beyond

ACHP, HealthScape Advisors and The Chartis Group discuss MA trends and MAforTomorrow in the Medicare Advantage in 2024 and Beyond webinar.

04/04/2024

Loading…
Making Health Care Better

ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow

Stay Connected